Skip to main content
FDA gives nod to tralokinumab for adults with moderate to severe AD
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
FDA gives nod to tralokinumab for adults with moderate to severe AD
User login
Username
Password
Reset your password
Concept
Lead
score
Dermatitis
1
0.95
Food and Drug Administration (FDA)
0
0.78
Atopic Dermatitis
0
0.53
Biologic Therapy
0
0.39
Topical Corticosteroid
0
0.28
Corticosteroids
0
0.2
Eczema
0
0.2
Interleukin
0
0.2
Monoclonal Antibody
0
0.2
Severity Index
0
0.2
Specialty
Lead
score
Dermatology
1
0.95
Family Medicine/Primary Care
0
0.99
Internal Medicine
0
0.99
Pharmacist
0
0.96
Allergy & Clinical Immunology
0
0.68